Search results :

Exenatide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: A10BX04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5
Nausea postmarketing — 1.3% - 44% 0% - 18% x x x x x
Diarrhoea postmarketing — 3.59% - 20% 3% - 8% x x x x x
Upper respiratory tract infection 1.35% - 17.2% x
Feeling jittery 9% 4% x x x x
Headache 4.24% - 14% 4% - 6% x x x x x
Pruritus 8% x x x
Viral diarrhoea 0% - 8.8% x x
Injection site haematoma 0.897% - 11% x x
Urinary tract infection 0.448% - 8.28% x
Dizziness 1.35% - 9% 6% x x x x x
Injection site pruritus 0.448% - 18.2% x x x
Asthenia 4% - 5% 1% - 2% x x x x
Nasopharyngitis 2.41% - 17.9% x
Back pain 3.03% - 4.22% x
Erythema 4% x x x
Vomiting postmarketing — 1% - 18.6% 0% - 4% x x x x x
Induration 4% x
Injection site nodule 0% - 10.5% x x
Dyspepsia 0.897% - 7.4% 0% - 3% x x x x x
Constipation postmarketing — 1.2% - 10.1% 2% x x x x x
Fatigue 0% - 6.1% x x x
Gastrooesophageal reflux disease 0.897% - 7.4% 0% - 1% x x x x x
Hyperhidrosis 3% 1% x x x x
Nodule 3% x x x
Sinusitis 1.2% - 6.9% x
Hypertension 1.21% - 3.14% x
Injection site erythema 0% - 7.4% x x x
Influenza 1.2% - 3.14% x
Arthralgia 0% - 4.82% x
Cough 1.2% - 3.59% x
Musculoskeletal pain 0% - 3.14% x
Gastroenteritis 0% - 2.03% x
Toothache 1.01% - 2.42% x
Abdominal pain upper 0.897% - 3.61% x
Oropharyngeal pain 0.602% - 3.59% x
Pain in extremity 0.69% - 2.41% x
Anxiety 0.606% - 2.07% x
Decreased appetite 0% - 5% 0% x x x x x
Depression 0% - 2.76% x
Injection site pain 0% - 2.07% x
Muscle spasms 0.448% - 2.07% x
Abdominal pain postmarketing — 0.897% - 3.61% x x x x x
Insomnia 0.448% - 2.76% x
Hypoglycaemia 0% - 43.5% x x x x x
Anorexia 0% - 2.03% x
Injection site induration 0% - 3.89% x
Abdominal discomfort 0% - 2.2% x
Diabetic neuropathy 0% - 2.07% x
Erectile dysfunction 0% - 2.76% x
Procedural pain 0% - 3.45% x
Abdominal distension postmarketing — 4% 1% x x x x x
Pancreatitis acute postmarketing, rare x x x
Alopecia postmarketing — 0% - 2.07% x x x x x
Anaphylactic shock very rare, postmarketing x x x x x
Angioedema postmarketing, rare x x x x x
Dehydration postmarketing, rare x x x x x
Dysgeusia postmarketing, uncommon x x x x x
Eructation postmarketing, uncommon x x x x x
Flatulence postmarketing — 2% 1% x x x x x
Haemorrhage postmarketing x x x x x
Hypersensitivity postmarketing x x
Renal failure acute postmarketing, rare x x x x x
Renal failure chronic postmarketing, rare x x x x
Urinary tract disorder postmarketing x x x x x
Urticaria postmarketing, rare x x x x x
Weight decreased rare x x x
Injection site reaction postmarketing, common x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Pancreatitis necrotising postmarketing x x
Pruritus generalised postmarketing, rare x x x
Drug interaction postmarketing x x x
Serum creatinine increased postmarketing, rare x x x x x
Rash papular postmarketing, rare x x x x x
Renal impairment postmarketing, rare x x x x x
Somnolence postmarketing, rare x x x x x
Ischaemia very rare x
Colitis ischaemic very rare x
Ileus very rare x
Alveolitis allergic x
Mental disorder x
Breast disorder x
Chest pain x
Coma x
Infection x
Connective tissue disorder x
Gastrointestinal disorder x x x
Hypokalaemia 0% - 2.76% x
Immune system disorder x x x
Mediastinal disorder x
Nervous system disorder x x x
Renal failure x
Convulsion x
Tachycardia x
Loss of consciousness x
Angiopathy x
Chills x
Injection site mass x
Malnutrition x x x
Diabetic x x
Neuroglycopenia x
Injection site dermatitis x
Blood glucose decreased x
Infestation NOS x
International normalised ratio increased x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

exenatide / exenatide

Side effects:41
Source:EMA

exenatide / exenatide

Side effects:49
Source:EMA

exenatide

Side effects:41
Source:FDA Structured Product Label

exenatide

Side effects:50
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label